Summer School for Innovative Science is specifically tailored for students and early-career scientists interested in or working with non-animal approaches and their application in various fields such as regulatory toxicology and biomedical research. All attendees will participate in plenary, joint interactive, and poster sessions throughout the week. For instructional sessions, attendees can choose from two tracks: toxicology and biomedical research.

View the Summer School Draft Program.

This program will offer:

  • Information about modern alternatives to the use of animals in toxicology and biomedical sciences
  • Diverse presentations, panel discussion, and break-out sessions with stakeholders in industry, academia, and government
  • Opportunities to present innovative research at poster sessions
  • Networking receptions and social engagement
  • Skill development including research funding, search strategies, and science communication
  • Laboratory visits with principal investigators utilizing cutting-edge technologies

Presentation topics include:

  • Organ-on-chip and their applications
  • Biomaterial & 3D printing approaches for engineering tissue
  • Tissue chips for disease modeling and efficacy testing
  • Cardiovascular bioinformatics and modeling
  • Mini-brain technology
  • Computational toxicology
  • In vitro assays for contract toxicology
  • Human-based models for developmental neurotoxicity
  • Ecotoxicology
  • Using NAMs for repeat dose assessment
  • And much more!

Why Should You Attend

Emilie Da SilvaEmilie Da Silva
PhD Candidate at Technical University of Denmark and former European Commission Trainee

As a PhD student working in the field of acute inhalation toxicity in vitro, I attended the JRC Summer School on Alternative Approaches for Risk Assessment to broaden my knowledge about methodologies for human health and environmental risk assessment using non-animal approaches within a regulatory context. After attending summer school, I was a lot more aware of different alternative methods under development for various endpoints and their specific challenges. I also got to meet people with whom I could discuss ideas and the obstacles I was facing, and whom I still talk to today. I highly recommend participating in this summer school! You will learn a lot about the current issues in the field of new alternative methodologies and meet people from different horizons but with the same ambition of revolutionizing toxicology.


Nathalia IndolfoNathalia Indolfo
Product Safety Analyst, Natura

The JRC Summer School on Non-Animal Approaches in Science was an amazing experience. It improved my knowledge on the latest approaches for in vitro/in silico toxicology testing, which benefited me a lot at work, besides being a great opportunity for networking and sharing of experiences. I totally recommend events like this.




Confirmed Speakers & Participants:

  • Luciene Balottin, InMetro
  • Kambez Benam, University of Colorado
  • Gundula Bosch, Johns Hopkins University
  • Tal Burt, Phase-0/Microdosing Network
  • Warren Casey, NICEATM, National Institutes of Health
  • Charu Chandrasekera, Canadian Centre for Alternatives to Animal Methods
  • Lowry Curley, Axosim
  • Maureen Gwinn, Environmental Protection Agency
  • Thomas Hartung, CAAT Johns Hopkins University
  • Esther Haugabrooks, Physicians Committee for Responsible Medicine
  • Kathrin Herrmann, CAAT Johns Hopkins University
  • Helena Hogberg, CAAT Johns Hopkins University
  • Nicole Kleinstreuer, NICEATM, National Institutes of Health
  • Ann Lam, Physicians Committee for Responsible Medicine
  • Thomas Leuchtefeld, InSilica
  • Talita Marin, LNBio/CNPEM
  • Gavin Maxwell, Unilever
  • Denise-Marie Ordway, Harvard University Shorenstein Center on Media, Politics and Public Policy
  • Francesca Pistollato, European Commission Joint Research Centre
  • Hans Raabe, Institute for In Vitro Sciences
  • Seila Selimovic, U.S. Department of Health and Human Services
  • Martin Stephens, CAAT Johns Hopkins University
  • Kristie Sullivan, Physicians Committee for Responsible Medicine
  • Misti Ushio, TARA Biosystems
  • Rob Wright, Johns Hopkins University